The study of lung adenocarcinoma serum biomarkers selected by surface-enhanced laser desorption ionization spectrometry
- VernacularTitle:表面增强激光解析离子化飞行时间质谱技术筛选肺腺癌血清肿瘤标记物
- Author:
Haiquan CHEN
;
Xiaoyang LUO
;
Wenjing WANG
;
Ping LIAO
;
Cuiqin XIANG
- Publication Type:Journal Article
- Keywords:
lung neoplasms;
adenocarcinoma;
biomarkers;
SELDI-TOF-MS;
proteomic
- From:China Oncology
1998;0(01):-
- CountryChina
- Language:Chinese
-
Abstract:
Background and Objective:Lung adenocarcinoma is,at present,the most common malignancy in the world and its overall 5-year survival rate is disappointing.Because most of the patients are diagnosed at advanced stage,early diagnosis may improve the prognosis of patients with lung adenocarcinoma.Surface-Enhanced Laser Desorption and Ionization Mass Spectrometry(SELDI) is one of the currently used techniques to identify biomarkers for cancers.This study explored the application of serum SELDI proteomic patterns to distinguish lung adenocarcinoma patients from healthy individuals.Methods:Serum samples from 71 lung adenocarcinoma patients,71 healthy volunteers with matched gender,age and history of smoking were analyzed using WCX2 ProteinChip to select potential biomarkers.Proteomic spectra were generated by mass spectrometry.Results:Five highly expressed potential biomarkers were identified with the relative molecular weights of 4047.79?1.60,4203.99?1.91,4959.81?2.13,5329.30?2.55 and 7760.12?4.11.The sensitivity for diagnosing lung adenocarcinoma was 90.14%,78.87%,50.70%,57.75%,73.24%;and specificity was 97.18%,92.96%,70.42%,76.06%,94.37%,when the critical point was made 1.5.Conclusions:SELDI-TOF-MS ProteinChip technology is a quick,easy,convenient,and highoutput analyzing method that it is capable of selecting several relatively specific,potential biomarkers from the serum of lung adenocarcinoma patients and may have clinic value.
